Seroprotection against tetanus in the Italian general population

Autor: Bagordo, Francesco, Grassi, Tiziana, Rota, Maria Cristina, Castiglia, Paolo, Baldovin, Tatjana, Della Polla, Giorgia, Panico, Alessandra, Ogliastro, Matilde, Marchi, Serena, Vicentini, Costanza, Immordino, Palmira, Savio, Marta, Gabutti, Giovanni, Bordino, V., Garlasco, J., Memoli, G., Giandomenico, A., Greco, F., Manini, I., Montomoli, E., Trombetta, CM., Baldo, V., De Fino, M., Marandola, M., Giberti, I., Orsi, A., Barrocci, S., La Porta, R., Arghittu, A., Dettori, M., Boni, M., Ghisellini, S., Maida, CM., Tramuto, F., Vitale, F., Gamper, A., Robatscher, E., Guido, M., Idolo, A., Angelillo, IF., Napolitano, F.

Publikováno v: In Vaccine 25 July 2024 42(19):4040-4045

Seasonal influenza vaccines: Variability of immune responses to B lineage viruses.

Autor: Miller MS; Michael G. DeGroote Institute for Infectious Disease Research, McMaster Immunology Research Centre, Department of Biochemistry & Biomedical Sciences, McMaster University, Hamilton, ON, Canada., Montomoli E; Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy., Leshem E; Infectious Disease Unit, Sheba Medical Center, Ramat-Gan, Israel, and Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel., Schotsaert M; Department of Microbiology, Global Health and Emerging Pathogens Institute, Icahn Genomics Institute, Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Weinke T; Klinikum Ernst von Bergmann, Potsdam, Germany., Vicic N; Moderna, Inc., Cambridge, MA, USA., Rudin D; Moderna, Inc., Cambridge, MA, USA.

Publikováno v: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2421096. Date of Electronic Publication: 2024 Nov 17.

Discovery and characterization of a pan-betacoronavirus S2-binding antibody.

Autor: Johnson NV; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712, USA., Wall SC; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN 73232, USA., Kramer KJ; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN 73232, USA., Holt CM; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA; Program in Chemical and Physical Biology, Vanderbilt University Medical Center, Nashville, TN 37232, USA., Periasamy S; Department of Pathology, University of Texas Medical Branch at Galveston, Galveston, TX 77555, USA; Galveston National Laboratory, University of Texas Medical Branch at Galveston, Galveston, TX 77555, USA., Richardson SI; National Institute for Communicable Diseases of the National Health Laboratory Service, 2131 Johannesburg, South Africa; South African MRC Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa., Manamela NP; National Institute for Communicable Diseases of the National Health Laboratory Service, 2131 Johannesburg, South Africa; South African MRC Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa., Suryadevara N; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA., Andreano E; Monoclonal Antibody Discovery (MAD) Lab, Fondazione Toscana Life Sciences, 53100 Siena, Italy., Paciello I; Monoclonal Antibody Discovery (MAD) Lab, Fondazione Toscana Life Sciences, 53100 Siena, Italy., Pierleoni G; Monoclonal Antibody Discovery (MAD) Lab, Fondazione Toscana Life Sciences, 53100 Siena, Italy., Piccini G; VisMederi Research S.r.l., 53100 Siena, Italy., Huang Y; Florida Research and Innovation Center, Cleveland Clinic, Port Saint Lucie, FL 34987, USA; Centers for Disease Control and Prevention, Atlanta, GA 30329, USA., Ge P; Florida Research and Innovation Center, Cleveland Clinic, Port Saint Lucie, FL 34987, USA., Allen JD; Florida Research and Innovation Center, Cleveland Clinic, Port Saint Lucie, FL 34987, USA., Uno N; Department of Infection Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44196, USA; Center for Vaccines and Immunology, University of Georgia, Athens, GA 30602, USA., Shiakolas AR; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN 73232, USA., Pilewski KA; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN 73232, USA., Nargi RS; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA., Sutton RE; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA., Abu-Shmais AA; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN 73232, USA., Parks R; Duke Human Vaccine Institute, Duke University, Durham, NC 27710, USA., Haynes BF; Duke Human Vaccine Institute, Duke University, Durham, NC 27710, USA; Departments of Medicine and Immunology, Duke University, Durham, NC 27710, USA., Carnahan RH; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN 37232, USA., Crowe JE Jr; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN 73232, USA; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN 37232, USA., Montomoli E; VisMederi Research S.r.l., 53100 Siena, Italy; VisMederi S.r.l, 53100 Siena, Italy; Department of Molecular and Developmental Medicine, University of Siena, 53100 Siena, Italy., Rappuoli R; Monoclonal Antibody Discovery (MAD) Lab, Fondazione Toscana Life Sciences, 53100 Siena, Italy; Department of Biotechnology, Chemistry and Pharmacy, University of Siena, 53100 Siena, Italy., Bukreyev A; Department of Pathology, University of Texas Medical Branch at Galveston, Galveston, TX 77555, USA; Galveston National Laboratory, University of Texas Medical Branch at Galveston, Galveston, TX 77555, USA., Ross TM; Florida Research and Innovation Center, Cleveland Clinic, Port Saint Lucie, FL 34987, USA; Department of Infection Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44196, USA; Center for Vaccines and Immunology, University of Georgia, Athens, GA 30602, USA; Department of Infectious Diseases, University of Georgia, Athens, GA 30602, USA., Sautto GA; Florida Research and Innovation Center, Cleveland Clinic, Port Saint Lucie, FL 34987, USA; Center for Vaccines and Immunology, University of Georgia, Athens, GA 30602, USA. Electronic address: sauttog@ccf.org., McLellan JS; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712, USA. Electronic address: jmclellan@austin.utexas.edu., Georgiev IS; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN 73232, USA; Vanderbilt Institute for Infection, Immunology, and Inflammation, Vanderbilt University Medical Center, Nashville, TN 37232, USA; Department of Computer Science, Vanderbilt University, Nashville, TN 37232, USA; Center for Structural Biology, Vanderbilt University, Nashville, TN 37232, USA; Program in Computational Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232, USA. Electronic address: ivelin.georgiev@vanderbilt.edu.

Publikováno v: Structure (London, England : 1993) [Structure] 2024 Nov 07; Vol. 32 (11), pp. 1893-1909.e11. Date of Electronic Publication: 2024 Sep 25.

Qualification of an enzyme-linked immunosorbent assay for quantification of anti-Vi IgG in human sera.

Autor: Carducci M; GSK Vaccines Institute for Global Health (GVGH) S.r.l., Siena, Italy., Massai L; GSK Vaccines Institute for Global Health (GVGH) S.r.l., Siena, Italy., Lari E; VisMederi S.r.l., Siena, Italy., Semplici B; VisMederi S.r.l., Siena, Italy., Aruta MG; GSK Vaccines Institute for Global Health (GVGH) S.r.l., Siena, Italy., De Simone D; GSK Vaccines Institute for Global Health (GVGH) S.r.l., Siena, Italy., Piu P; VisMederi S.r.l., Siena, Italy., Montomoli E; VisMederi S.r.l., Siena, Italy.; Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy., Berlanda Scorza F; GSK Vaccines Institute for Global Health (GVGH) S.r.l., Siena, Italy., Grappi S; VisMederi S.r.l., Siena, Italy., Iturriza-Gómara M; GSK Vaccines Institute for Global Health (GVGH) S.r.l., Siena, Italy., Canals R; GSK Vaccines Institute for Global Health (GVGH) S.r.l., Siena, Italy., Rondini S; GSK Vaccines Institute for Global Health (GVGH) S.r.l., Siena, Italy., Rossi O; GSK Vaccines Institute for Global Health (GVGH) S.r.l., Siena, Italy.

Publikováno v: Frontiers in immunology [Front Immunol] 2024 Oct 16; Vol. 15, pp. 1466869. Date of Electronic Publication: 2024 Oct 16 (Print Publication: 2024).

Prevalence of Influenza B/Yamagata Viruses From Season 2012/2013 to 2021/2022 in Italy as an Indication of a Potential Lineage Extinction.

Autor: Marchi S; Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy., Bruttini M; Tuscan Centre of Precision Medicine, Department of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy., Milano G; Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy., Manini I; Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy., Chironna M; Department of Interdisciplinary Medicine, University of Bari Aldo Moro, Bari, Italy., Pariani E; Department of Biomedical Sciences for Health, University of Milan, Milan, Italy., Manenti A; VisMederi srl, Siena, Italy., Kistner O; VisMederi srl, Siena, Italy., Montomoli E; Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy.; VisMederi srl, Siena, Italy.; VisMederi Research srl, Siena, Italy., Temperton N; Viral Pseudotype Unit, Medway School of Pharmacy, University of Kent and Greenwich Chatham Maritime, Kent, UK., Trombetta CM; Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy.; VisMederi Research srl, Siena, Italy.

Publikováno v: Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2024 Sep; Vol. 18 (9), pp. e13359.